CD8A and hepatocellular carcinoma: To address this issue in more depth, we performed a comprehensive phenotypical analysis of the enriched antigen-experienced MAGE-A196- and MAGE-A3271-specific CD8+ T cells obtained from blood of patients with HCC compared to liver cirrhosis, respectively.